Home » Stocks » MeiraGTx Holdings

MeiraGTx Holdings PLC (MGTX)

Stock Price: $12.94 USD 0.02 (0.15%)
Updated Oct 20, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 483.48M
Revenue (ttm) 17.21M
Net Income (ttm) -57.04M
Shares Out 37.36M
EPS (ttm) -1.58
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 20, 2020
Last Price $12.94
Previous Close $12.92
Change ($) 0.02
Change (%) 0.15%
Day's Open 13.09
Day's Range 12.45 - 13.17
Day's Volume 36,339
52-Week Range 8.82 - 22.32

More Stats

Market Cap 483.48M
Enterprise Value 309.36M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 37.36M
Float 25.01M
EPS (basic) -1.54
EPS (diluted) -1.58
FCF / Share -2.15
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 390,590
Short Ratio 2.91
Short % of Float 1.56%
Beta 1.37
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 28.10
PB Ratio 2.82
Revenue 17.21M
Operating Income -74.46M
Net Income -57.04M
Free Cash Flow -79.37M
Net Cash 174.12M
Net Cash / Share 4.66
Gross Margin 77.24%
Operating Margin -432.71%
Profit Margin n/a
FCF Margin -461.20%
ROA -13.16%
ROE -37.73%
ROIC -87.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 6
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(157.57% upside)
Current: $12.94
Target: 33.33
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-71.56-78.10-31.68-20.06
Net Income-54.75-82.87-31.04-19.49
Shares Outstanding33.1618.958.5731.10
Earnings Per Share-1.65-4.47-3.72-0.63
Operating Cash Flow20.04-58.89-18.06-14.37
Capital Expenditures-8.98-11.26-10.54-2.59
Free Cash Flow11.06-70.15-28.59-16.96
Cash & Equivalents22768.208.6717.92
Total Debt23.180.031.510.01
Net Cash / Debt20468.177.1617.91
Book Value19181.06-47.37-17.14
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name MeiraGTx Holdings PLC
Country United States
Employees 168
CEO Alexandria Forbes

Stock Information

Ticker Symbol MGTX
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: MGTX


MeiraGTx Holdings plc, a clinical-stage gene therapy company, focusing on developing treatments for patients living with serious diseases. The company develops various therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; neurodegenerative diseases, such as amyothrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. The company was founded in 2015 and is based in New York, New York.